1. Home
  2. WF vs BIO Comparison

WF vs BIO Comparison

Compare WF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WF

Woori Financial Group Inc. (each representing three (3) shares of)

HOLD

Current Price

$59.58

Market Cap

14.1B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$302.70

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WF
BIO
Founded
1899
1952
Country
South Korea
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WF
BIO
Price
$59.58
$302.70
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$358.50
AVG Volume (30 Days)
56.6K
158.3K
Earning Date
10-29-2025
02-12-2026
Dividend Yield
3.60%
N/A
EPS Growth
20.51
N/A
EPS
2.97
N/A
Revenue
$8,054,512,650.00
$2,557,500,000.00
Revenue This Year
N/A
$1.62
Revenue Next Year
$4.37
$2.26
P/E Ratio
$6.60
N/A
Revenue Growth
23.56
N/A
52 Week Low
$29.44
$211.43
52 Week High
$59.88
$373.69

Technical Indicators

Market Signals
Indicator
WF
BIO
Relative Strength Index (RSI) 66.39 42.26
Support Level $57.13 $295.01
Resistance Level $58.27 $307.07
Average True Range (ATR) 0.97 8.09
MACD 0.16 -1.25
Stochastic Oscillator 95.70 22.23

Price Performance

Historical Comparison
WF
BIO

About WF Woori Financial Group Inc. (each representing three (3) shares of)

Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: